Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner

被引:18
作者
Smola-Hess, S [1 ]
de Silva, US [1 ]
Hadaschik, D [1 ]
Pfister, HJ [1 ]
机构
[1] Univ Cologne, Inst Virol, D-50935 Cologne, Germany
关键词
D O I
10.1099/0022-1317-82-10-2335
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cervical carcinoma cells producing high levels of interleukin-6 (IL-6) were shown to be unresponsive to the cytokine IL-6 due to the loss of their IL-6 receptor. Addition of IL-6 receptor in a soluble form restores IL-6 signalling in SW756 carcinoma cells. This leads to a rapid and strong activation of the transcription factor signal transducer and activator of transcription 3 (STAT3). Nuclear factor IL-6 (NF-IL6, C/EBP beta) was induced only as a late event. While C/EBP beta significantly repressed the human papillomavirus type 18 long control region (HPV18-LCR), IL-6 signalling unexpectedly activated the HPV18-LCR in these cells. This IL-6 receptor-mediated induction could be completely reverted by transfection of a dominant-negative STAT3 but not STAT1 expression construct, indicating that STAT3 might play an important role in HPV18 oncogene promoter activation.
引用
收藏
页码:2335 / 2339
页数:5
相关论文
共 34 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]  
Altenburg A, 1999, J IMMUNOL, V162, P4140
[3]   A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region [J].
Bauknecht, T ;
See, RH ;
Shi, Y .
JOURNAL OF VIROLOGY, 1996, 70 (11) :7695-7705
[4]   Response to IL-6 of HPV-18 cervical carcinoma cell lines [J].
Bauknecht, T ;
Randelzhofer, B ;
Schmitt, B ;
Ban, Z ;
Hernando, JJ ;
Bauknecht, T .
VIROLOGY, 1999, 258 (02) :344-354
[5]  
BAUMANN H, 1992, J BIOL CHEM, V267, P19744
[6]  
BOULTON TG, 1994, J BIOL CHEM, V269, P11648
[7]   GROWTH-INHIBITION OF HUMAN-BREAST CARCINOMA AND LEUKEMIA LYMPHOMA CELL-LINES BY RECOMBINANT INTERFERON-BETA-2 [J].
CHEN, L ;
MORY, Y ;
ZILBERSTEIN, A ;
REVEL, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :8037-8041
[8]  
DAEIPOUR M, 1993, J IMMUNOL, V150, P4743
[9]   INTERLEUKIN-6 (IL-6) FUNCTIONS AS AN AUTOCRINE GROWTH-FACTOR IN CERVICAL CARCINOMAS IN-VITRO [J].
EUSTACE, D ;
HAN, X ;
GOODING, R ;
ROWBOTTOM, A ;
RICHES, P ;
HEYDERMAN, E .
GYNECOLOGIC ONCOLOGY, 1993, 50 (01) :15-19
[10]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314